These findings underscore the importance of careful threshold selection when utilizing PLAC1 as a prognostic biomarker and suggest that PLAC1 may serve as a context-dependent indicator of clinical outcome, with its prognostic value varying substantially across different tumor types. Here, PLAC1 is linked to neoplasm.